Neurology, ophthalmology, orl
Zeile 11: | Zeile 11: | ||
− | + | ||
− | + | ||
{{ttp|p=32348111|t=ä. Is the Collapse of the Respiratory Center in the Brain Responsible for Respiratory Breakdown in COVID-19 Patients?|pdf=|usr=}} | {{ttp|p=32348111|t=ä. Is the Collapse of the Respiratory Center in the Brain Responsible for Respiratory Breakdown in COVID-19 Patients?|pdf=|usr=}} | ||
Zeile 25: | Zeile 24: | ||
{{tp|p=32265202|t=2020. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease |pdf=|usr=}} | {{tp|p=32265202|t=2020. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease |pdf=|usr=}} | ||
− | + | ||
Zeile 40: | Zeile 39: | ||
{{tp|p=32323704|t=2020. COVID-19 emergency in the cruise s ship: a case report of conjunctivitis |pdf=|usr=}} | {{tp|p=32323704|t=2020. COVID-19 emergency in the cruise s ship: a case report of conjunctivitis |pdf=|usr=}} | ||
− | + | ||
{{tp|p=32354654|t=ä. Corona virus disease-19 (COVID-19) presenting as conjunctivitis: atypically high-risk during a pandemic |pdf=|usr=}} | {{tp|p=32354654|t=ä. Corona virus disease-19 (COVID-19) presenting as conjunctivitis: atypically high-risk during a pandemic |pdf=|usr=}} | ||
{{tp|p=32328364|t=ä. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy |pdf=|usr=}} | {{tp|p=32328364|t=ä. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy |pdf=|usr=}} | ||
Zeile 72: | Zeile 71: | ||
− | |||
− | |||
{{tp|p=32232433|t=2020. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China |pdf=|usr=}} | {{tp|p=32232433|t=2020. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China |pdf=|usr=}} | ||
Zeile 81: | Zeile 78: | ||
− | |||
− | |||
− | |||
− | |||
{{tp|p=32364121|t=ä. Infeccion por SARS-CoV-2 asociada a diplopia y anticuerpos antirreceptor de acetilcolina |pdf=|usr=}} | {{tp|p=32364121|t=ä. Infeccion por SARS-CoV-2 asociada a diplopia y anticuerpos antirreceptor de acetilcolina |pdf=|usr=}} | ||
Zeile 94: | Zeile 87: | ||
{{tp|p=32359841|t=ä. A Rashomon Moment? Ocular Involvement and COVID-19 |pdf=|usr=}} | {{tp|p=32359841|t=ä. A Rashomon Moment? Ocular Involvement and COVID-19 |pdf=|usr=}} | ||
− | + | ||
{{tp|p=32246403|t=ä. The brain, another potential target organ, needs early protection from SARS-CoV-2 neuroinvasion |pdf=|usr=}} | {{tp|p=32246403|t=ä. The brain, another potential target organ, needs early protection from SARS-CoV-2 neuroinvasion |pdf=|usr=}} | ||
{{tp|p=32344366|t=2020. Focal status epilepticus as unique clinical feature of COVID-19: A case report |pdf=|usr=}} | {{tp|p=32344366|t=2020. Focal status epilepticus as unique clinical feature of COVID-19: A case report |pdf=|usr=}} | ||
− | + | ||
− | + | ||
{{tp|p=32378854|t=2020. Covid-19 med nedsatt lukte- og smakssans som eneste symptom |pdf=|usr=}} | {{tp|p=32378854|t=2020. Covid-19 med nedsatt lukte- og smakssans som eneste symptom |pdf=|usr=}} | ||
Zeile 105: | Zeile 97: | ||
− | + | ||
{{tp|p=32374367|t=ä. Delirium: a missing piece in the COVID-19 pandemic puzzle |pdf=|usr=}} | {{tp|p=32374367|t=ä. Delirium: a missing piece in the COVID-19 pandemic puzzle |pdf=|usr=}} | ||
Zeile 132: | Zeile 124: | ||
{{tp|p=32330304|t=2020. Conjunctivitis and COVID-19: A meta-analysis |pdf=|usr=}} | {{tp|p=32330304|t=2020. Conjunctivitis and COVID-19: A meta-analysis |pdf=|usr=}} | ||
− | |||
− | |||
{{tp|p=32275079|t=2020. SARS-CoV-2 may be related to conjunctivitis but not necessarily spread through the conjunctiva SARS-CoV-2 and conjunctiva |pdf=|usr=}} | {{tp|p=32275079|t=2020. SARS-CoV-2 may be related to conjunctivitis but not necessarily spread through the conjunctiva SARS-CoV-2 and conjunctiva |pdf=|usr=}} | ||
− | |||
− | |||
− | |||
{{tp|p=32267483|t=2020. Sudden and Complete Olfactory Loss Function as a Possible Symptom of COVID-19 |pdf=|usr=}} | {{tp|p=32267483|t=2020. Sudden and Complete Olfactory Loss Function as a Possible Symptom of COVID-19 |pdf=|usr=}} | ||
Zeile 148: | Zeile 135: | ||
{{tp|p=32358218|t=2020. COVID-19 presenting with ophthalmoparesis from cranial nerve palsy |pdf=|usr=}} | {{tp|p=32358218|t=2020. COVID-19 presenting with ophthalmoparesis from cranial nerve palsy |pdf=|usr=}} | ||
− | + | ||
− | + | ||
{{tp|p=32303650|t=2020. Miller Fisher Syndrome and polyneuritis cranialis in COVID-19 |pdf=|usr=}} | {{tp|p=32303650|t=2020. Miller Fisher Syndrome and polyneuritis cranialis in COVID-19 |pdf=|usr=}} | ||
Zeile 160: | Zeile 146: | ||
{{tp|p=32277751|t=2020. Presentation of new onset anosmia during the COVID-19 pandemic |pdf=|usr=}} | {{tp|p=32277751|t=2020. Presentation of new onset anosmia during the COVID-19 pandemic |pdf=|usr=}} | ||
− | + | ||
{{tp|p=32316719|t=2020. Expression analysis of 2019-nCoV related ACE2 and TMPRSS2 in eye tissues |pdf=|usr=}} | {{tp|p=32316719|t=2020. Expression analysis of 2019-nCoV related ACE2 and TMPRSS2 in eye tissues |pdf=|usr=}} | ||
{{tp|p=32306616|t=2020. Strengthening basic and clinical research on ocular infection caused by coronavirus |pdf=|usr=}} | {{tp|p=32306616|t=2020. Strengthening basic and clinical research on ocular infection caused by coronavirus |pdf=|usr=}} | ||
{{tp|p=C7200324|t=ä. SARS-CoV-2 infection associated with diplopia and anti-acetylcholine receptor antibodies? |pdf=|usr=}} | {{tp|p=C7200324|t=ä. SARS-CoV-2 infection associated with diplopia and anti-acetylcholine receptor antibodies? |pdf=|usr=}} | ||
− | + | ||
{{tp|p=32377594|t=2020. Haemorrhagic conjunctivitis with pseudomembranous related to SARS-CoV-2 |pdf=|usr=}} | {{tp|p=32377594|t=2020. Haemorrhagic conjunctivitis with pseudomembranous related to SARS-CoV-2 |pdf=|usr=}} | ||
Zeile 172: | Zeile 158: | ||
{{tp|p=32387342|t=ä. Letter to editor: Severe brain haemorrhage and concomitant COVID-19 Infection: A neurovascular complication of COVID-19 |pdf=|usr=}} | {{tp|p=32387342|t=ä. Letter to editor: Severe brain haemorrhage and concomitant COVID-19 Infection: A neurovascular complication of COVID-19 |pdf=|usr=}} | ||
− | + | ||
Zeile 179: | Zeile 165: | ||
− | + | ||
{{tp|p=32409210|t=ä. Coexistence of COVID-19 and acute ischemic stroke report of four cases |pdf=|usr=}} | {{tp|p=32409210|t=ä. Coexistence of COVID-19 and acute ischemic stroke report of four cases |pdf=|usr=}} | ||
− | |||
− | |||
− | |||
{{tp|p=32413767|t=2020. Myasthenic crisis in COVID-19 |pdf=|usr=}} | {{tp|p=32413767|t=2020. Myasthenic crisis in COVID-19 |pdf=|usr=}} | ||
Version vom 11. Juni 2020, 12:10 Uhr
coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.
- Cerebral embolism
- Smell and taste disorder
- Brain infection Neurotropism
- Guillain-Barre Syndrome
- Autoimmune Neuropathies
- Neurology Reviews and Multitopic
32310553 2020. Ophthalmic Manifestations Of Coronavirus (COVID-19)
32348111 ä. Is the Collapse of the Respiratory Center in the Brain Responsible for Respiratory Breakdown in COVID-19 Patients? |
32367205 ä. SARS-CoV-2 can induce brain and spine demyelinating lesions
32377594 ä. Haemorrhagic conjunctivitis with pseudomembranous related to SARS-CoV-2
32278470 ä. Upper airway symptoms in coronavirus disease 2019 (COVID-19)
32276732 ä. Hearing loss and COVID-19: A note
32327217 ä. COVID-19 and hearing difficulties
32345855 2020. Coronavirus Disease 2019 Pandemic Acute Respiratory Distress Syndrome Survivors: Pain After the Storm?
32265202 2020. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease
32298803 ä. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms?
32322822 ä. THREE INSIGHTS ON PSYCHONEUROIMMUNOLOGY OF MOOD DISORDERS TO BE TAKEN FROM THE COVID-19 PANDEMIC
32283246 ä. Treating the Mental Health Effects of COVID-19: The Need for At-Home Neurotherapeutics Is Now
32284146 ä. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19)
32323704 2020. COVID-19 emergency in the cruise s ship: a case report of conjunctivitis
32354654 ä. Corona virus disease-19 (COVID-19) presenting as conjunctivitis: atypically high-risk during a pandemic
32328364 ä. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy
32283980 2020. Clinical Presentation of COVID-19: A Systematic Review Focusing on Upper Airway Symptoms
32370982 ä. Ensuring mental health care during the SARS-CoV-2 epidemic in France: a narrative review
32362868 2020. Long-Term Neurological Threats of COVID-19: A Call to Update the Thinking About the Outcomes of the Coronavirus Pandemic
32333104 ä. A child confirmed COVID-19 with only symptoms of conjunctivitis and eyelid dermatitis
32328758 ä. The prevalence of ophthalmic manifestations in COVID-19 and the diagnostic value of ocular tissue/fluid
32363146 2020. COVID-19 Presenting with Seizures
32373467 2020. Conjunctivitis can be the only presenting sign and symptom of COVID-19
32314322 ä. COVID-19 and the eye immunity: lesson learned from the past and possible new therapeutic insights
32332516 2020. Precaution and prevention of coronavirus disease 2019 infection in the eye
32353982 2020. The Ocular Surface and the Coronavirus Disease 2019: Does a Dual Ocular Route Exist?
32307298 ä. Severe cerebral involvement in adult-onset hemophagocytic lymphohistiocytosis
32354690 ä. COVID 19 infection presenting as motor peripheral neuropathy
32327279 ä. Unilateral conjunctivitis as first presentation of Coronavirus Disease 2019 (COVID-19): A telemedicine diagnosis
32334847 ä. Ocular manifestation as first sign of Coronavirus Disease 2019 (COVID-19): interest of telemedicine during the pandemic context
32165057 2020. Le nouveau Coronavirus Covid-19: quels risques ophtalmiques?
32232433 2020. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China
32361098 2020. Does infection of 2019 novel coronavirus cause acute and/or chronic sialadenitis?
32364121 ä. Infeccion por SARS-CoV-2 asociada a diplopia y anticuerpos antirreceptor de acetilcolina
32322398 2020. COVID-19 and intracerebral haemorrhage: causative or coincidental?
32175797 2020. Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals
32289466 2020. The evidence of SARS-CoV-2 infection on ocular surface
32359840 ä. Ocular Findings and Proportion with Conjunctival SARS-COV-2 in COVID-19 Patients
32359841 ä. A Rashomon Moment? Ocular Involvement and COVID-19
32246403 ä. The brain, another potential target organ, needs early protection from SARS-CoV-2 neuroinvasion
32344366 2020. Focal status epilepticus as unique clinical feature of COVID-19: A case report
32378854 2020. Covid-19 med nedsatt lukte- og smakssans som eneste symptom
32359765 ä. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System
32374367 ä. Delirium: a missing piece in the COVID-19 pandemic puzzle
32336042 2020. Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19
32327427 2020. Myositis as a manifestation of SARS-CoV-2
32086236 2020. Novel Coronavirus disease 2019 (COVID-19): The importance of recognising possible early ocular manifestation and using protective eyewear
32379592 2020. Emerging evidence for neuropsycho-consequences of COVID-19
32333819 2020. COVID-19: what if the brain had a role in causing the deaths?
32301553 2020. Lack of dyspnea in patients with Covid-19: another neurological conundrum? |
32317428 2020. What ophthalmologists should know about conjunctivitis in the COVID-19 pandemic?
32246784 ä. An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID?19 |
32352575 2020. Comment on "The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients"
32374427 2020. Expression of the COVID-19 receptor ACE2 in the human conjunctiva
32246782 2020. Respiratory failure alone does not suggest central nervous system invasion by SARS-CoV-2
32330304 2020. Conjunctivitis and COVID-19: A meta-analysis
32275079 2020. SARS-CoV-2 may be related to conjunctivitis but not necessarily spread through the conjunctiva SARS-CoV-2 and conjunctiva
32267483 2020. Sudden and Complete Olfactory Loss Function as a Possible Symptom of COVID-19
32291797 2020. SARS-CoV-2: At the Crossroad Between Aging and Neurodegeneration
32380269 ä. The COVID-19 pandemic: consideration for brain infection
32358218 2020. COVID-19 presenting with ophthalmoparesis from cranial nerve palsy
32303650 2020. Miller Fisher Syndrome and polyneuritis cranialis in COVID-19
32369434 2020. Acute Parotitis: A Possible Precocious Clinical Manifestation of SARS-CoV-2 Infection?
32228363 2020. COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features
32338254 2020. Olfactory and rhinological evaluations in SARS-CoV-2 patients complaining of olfactory loss
32319971 2020. Anosmia as a prominent symptom of COVID-19 infection
32240279 2020. Isolated sudden onset anosmia in COVID-19 infection A novel syndrome?
32277751 2020. Presentation of new onset anosmia during the COVID-19 pandemic
32316719 2020. Expression analysis of 2019-nCoV related ACE2 and TMPRSS2 in eye tissues
32306616 2020. Strengthening basic and clinical research on ocular infection caused by coronavirus
C7200324 ä. SARS-CoV-2 infection associated with diplopia and anti-acetylcholine receptor antibodies?
32377594 2020. Haemorrhagic conjunctivitis with pseudomembranous related to SARS-CoV-2
32389704 ä. Pain: A potential new label of COVID-19
32387342 ä. Letter to editor: Severe brain haemorrhage and concomitant COVID-19 Infection: A neurovascular complication of COVID-19
32382463 ä. Rhabdomyolysis as a Presentation of 2019 Novel Coronavirus Disease
32382146 ä. Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea
32409210 ä. Coexistence of COVID-19 and acute ischemic stroke report of four cases
32413767 2020. Myasthenic crisis in COVID-19
32387762 2020. Transient cortical blindness in COVID-19 pneumonia; a PRES-like syndrome: Case report
32355557 ä. Ophthalmic manifestations of novel coronaviruses: precautionary measures and diagnostic possibilities
32388138 2020. Hypothesized behavioral host manipulation by SARS-CoV2/COVID-19 infection |
32380269 2020. The COVID-19 Pandemic: Consideration for Brain Infection
32342265 ä. Coronavirus disease 2019 and obstructive sleep apnea syndrome